The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
GEIS 39: Phase II trial of nabpaclitaxel for the treatment of patient with multiply relapsed/refractory desmoplastic small round cell tumor (DSRCT) and Ewing sarcoma (EwS).
 
Jaume Mora
Consulting or Advisory Role - YmAbs Therapeutics Inc
Speakers' Bureau - YmAbs Therapeutics Inc
Expert Testimony - YmAbs Therapeutics Inc
Travel, Accommodations, Expenses - YmAbs Therapeutics Inc
 
Mariona Suñol
No Relationships to Disclose
 
Nadia Hindi
Honoraria - PharmaMar
Research Funding - Adaptimmune (Inst); Amgen (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Daychii (Inst); Deciphera (Inst); Eisai (Inst); FORMA Therapeutics (Inst); GlaxoSmithKline (Inst); Immix BioPharma (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Lixte Biotechnology (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Alicia Castañeda
No Relationships to Disclose
 
Andrés Redondo
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; GlaxoSmithKline; PharmaMar; Roche
Speakers' Bureau - AstraZeneca; Clovis Oncology; GlaxoSmithKline; PharmaMar; Roche
Research Funding - Eisai (Inst); Pharmamar (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar
 
Francisco José Bautista Sirvent
No Relationships to Disclose
 
Robert Diaz Beveridge
No Relationships to Disclose
 
Antonio Lopez-Pousa
No Relationships to Disclose
 
Jose A. Lopez-Martin
Stock and Other Ownership Interests - PharmaMar
Consulting or Advisory Role - PharmaMar
Travel, Accommodations, Expenses - PharmaMar
 
Javier Martin Broto
Honoraria - Bayer; Eisai; Lilly; PharmaMar
Consulting or Advisory Role - Amgen; Bayer; GlaxoSmithKline; Novartis; PharmaMar
Speakers' Bureau - PharmaMar
Research Funding - Amgen (Inst); Bayer (Inst); Blueprint Medicines (Inst); Daiichi Sankyo (Inst); Deciphera (Inst); Eisai; Eisai (Inst); FORMA Therapeutics (Inst); GlaxoSmithKline (Inst); Immix BioPharma (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Lixte Biotechnology (Inst); Nektar (Inst); Novartis; Novartis (Inst); PharmaMar
Expert Testimony - Novartis; PharmaMar
Travel, Accommodations, Expenses - Pfizer; PharmaMar